Gene Query: GOPC

Dataset Description Geneva Score
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 40.78
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 40.78
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 36.82
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 36.82
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 28.64
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 28.55
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 25.16
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 24.38
Nutritional control of protein translation 24.16
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 21.4
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 20.76
Altering cancer transcriptomes using epigenomic inhibitors 20.25
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 20.25
Cleavage Factor Im as a key regulator of 3’ UTR length 20.15
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 19.95
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 19.91
Peptidomimetic blockade of MYB in acute myeloid leukemia 19.91
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 19.09
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 19.09
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 18.85
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 18.38
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 17.69
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 17.24
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 16.91
16.33
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 16.3
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 15.9
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 15.9
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 15.31
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 15.31
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 15.26
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 15.21
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 14.78
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 14.78
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 14.38
Total RNA-seq in ALL-SIL upon TLX1 knockdown 14.37
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 14.22
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 13.95
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 13.69
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 13.52
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 13.44
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 13.42
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 12.98
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 12.66
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 12.3
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 12.26
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 12.23
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 12.23
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 12.2
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 12.18
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 12.13
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 11.94
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 11.83
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 11.83
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 11.78
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 11.77
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 11.73
IRF2 is a master regulator of human keratinocyte stem cell fate 11.73
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.7
A549 cells and MSR-A549 cells 11.62
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 11.62
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 11.61
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 11.61
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 11.61
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 11.55
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 11.49
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 11.36
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 11.34
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 11.31
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 11.27
Biological effect of chronic mistranslation in mammalian cells 11.25
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 11.13
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 11.12
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 11.1
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 10.9
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 10.9
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 10.87
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 10.77
Transcriptomic analysis of LSD1 10.76
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 10.58
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 10.21
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 10.1
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 10.04
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 10.01
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 10.0
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.99
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 9.97
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 9.97
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 9.96
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 9.93
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 9.91
Reassessment of Exosome Composition 9.89
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 9.82
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.76
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 9.75
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.69
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 9.69
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 9.69
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 9.68
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 9.56
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 9.45
R430: A potent inbibitor of DNA and RNA viruses 9.42
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.38
MYC dependent mRNA translation shapes gene expression and cell biology 9.36
IL-33 activates tumor stroma to promote intestinal polyposis 9.34
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 9.34
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 9.32
A sister of NANOG regulates genes expressed in pre-implantation human development 9.28
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.26
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.26
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.21
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 9.04
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 9.04
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.04
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.94
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 8.92
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 8.85
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.8
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 8.7
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 8.7
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 8.65
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 8.62
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 8.5
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 8.5
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 8.49
Genome-wide discovery of human splicing branchpoints [RNAse] 8.38
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.33
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.33
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.32
High level DNA repair gene expression in human ES cells 8.31
Ectoderm specification of H1 human embryonic stem cells 8.3
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 8.29
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 8.28
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.25
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 8.22
Gene expression profiling of leukemia cells following asparagine depletion 8.21
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 8.2
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 8.2
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.15
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 8.11
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.07
RNAseq of HEK293 cells after Chtop knockdown 8.07
Toxoplasma gondii infection of human retinal pigment epithelial cells 8.04
Neurofibroma 8.03
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 8.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.99
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 7.99
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.98
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.96
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.96
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 7.95
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 7.95
MYCL and EP400 are required for Max and MCPyV mediated gene activation 7.95
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.95
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 7.72
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.71
Fbxo32 mediated gene expression program underlies EMT and metastasis 7.69
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 7.67
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 7.65
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.65
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 7.61
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 7.61
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 7.59
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.57
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 7.54
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.52
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 7.5
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 7.5
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.4
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 7.4
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 7.4
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 7.37
3’ Uridylation Expands miRNA Target Repertoire 7.36
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 7.28
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.27
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 7.26
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 7.26
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 7.26
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 7.26
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 7.23
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.18
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.18
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 7.17
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 7.17
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.17
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.12
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 7.12
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.09
Lineage specific differentiation is influenced by state of human pluripotency 7.07
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 7.07
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.07
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 7.05
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 7.04
Effect of PRDM11 depletion in U2932 cells 7.04
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 7.04
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 7.04
RNA-seq of human fibroblasts after irradiation 7.03
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 7.02
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 7.01
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 7.0
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 7.0
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.99
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.97
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.96
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.96
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 6.95
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.87
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.84
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 6.84
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.8
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.8
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.79
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.79
Seletive inhibition of CDK9 in DLBCL cell lines 6.77
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 6.7
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 6.69
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 6.68
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.66
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 6.63
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 6.61
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 6.57
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 6.57
Identification of differentially expressed genes between senescence and senescence bypass cells 6.57
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 6.57
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 6.57
Transcriptome of U251 cells overexpression complement component 7 6.55
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.55
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 6.54
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 6.53
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.51
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 6.47
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.44
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 6.42
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.41
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 6.4
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.4
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.4
Pharmacologic inhibition of STAT5 in AML 6.39
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 6.39
Transciptomic profiling of human fetal lung samples 6.37
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 6.35
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 6.35
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.35
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.33
Differential Gene Expression between MCF10A and MCF7 cells 6.32
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.3
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.26
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.24
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.23
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.16
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.14
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 6.14
Human embryonic stem cells in E8 and AKIT culture medium 6.14
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 6.09
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 6.06
TFAP2C signalling in human fibroblasts 6.04
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.03
Modeling Familial Cancer with iPSC Approaches 6.03
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 6.02
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 6.02
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.97
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  5.97
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 5.95
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.93
Electronic cigarettes 5.91
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.88
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.88
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 5.86
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.85
SLIGRL-induced gene expression changes in NHEK cells 5.83
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.8
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 5.79
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 5.67
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 5.67
RNA-sequencing of human tendon after injury 5.67
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 5.58
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 5.57
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 5.57
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 5.51
Global Mapping of Human RNA-RNA Interactions 5.51
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 5.49
Endothelial gene expression analysis 5.48
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.48
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.46
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 5.44
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 5.38
Aneuploidy triggers an immune response 5.37
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.33
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.33
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.32
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 5.31
RNA-seq of shEZH2 cells 5.23
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 5.17
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 5.17
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 5.15
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.09
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.09
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.08
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.03
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.01
Exploring ILF2 regulatory genes by next-generation sequencing 4.99
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 4.93
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 4.93
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.91
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 4.87
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 4.86
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.86
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.83
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.83
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.79
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 4.74
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.7
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 4.66
Effect of PBK knockdown on C4-2 cell transcriptome 4.6
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.54
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 4.47
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 4.43
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.4
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.4
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.37
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.32
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 4.26
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.26
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.16
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 4.14
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.14
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 4.13
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 4.04
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.02
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 4.0
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 4.0
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.98
Global response to chemotherapy-induced apoptosis 3.95
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.95
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.91
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.9
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.87
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 3.85
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.8
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.8
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.77
RNA sequencing of primary human platelets and in vitro cell lines 3.76
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.76
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.74
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.55
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.54
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.52
The contribution of Alu exons to the human proteome 3.51
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.49
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 3.44
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 3.44
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.43
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.41
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 3.41
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 3.41
Single-cell analysis of human kidney organoids 3.4
K562 polyA RNA-Seq 3.39
Effect of drugs on transcriptomic profiles 3.36
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.36
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 3.36
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  3.29
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.28
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 3.27
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.26
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 3.22
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.22
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.22
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 3.19
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 3.02
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 3.0
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.96
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.91
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.91
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.87
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.87
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.83
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.83
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 2.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.82
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.82
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 2.82
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 2.81
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.79
6mer seed toxicity in viral microRNAs 2.78
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.77
scRNASeq analysis of cycling cardiomyocytes 2.77
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.72
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.71
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.66
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.61
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.6
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.5
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 2.47
The transcriptome effect of overexpressing EZH2 in MCF7 2.47
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 2.44
The circadian transcriptional landscape in primary human mammary epithelial cells 2.43
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.43
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.43
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.42
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.42
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.34
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.33
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.32
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.3
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.28
Loss of CREBBP results in gene expression repression in lymphoma cells 2.28
Analysis of transcriptional regulation by Myt1 and Myt1l 2.26
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.26
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.23
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.23
Investigate A2M treatment on human prostate cancer xenograft in mice 2.2
Investigate A2M treatment on human prostate cancer and mouse liver 2.2
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.17
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.15
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 2.1
6mer seed toxicity in tumour suppressive microRNAs 2.09
Fusion discovery in breast cancer cell line 2.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.02
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.02
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.02
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 1.97
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.96
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.74
HBEC-shp53-PCHD7 1.72
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.71
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.7
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.57
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.5
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.49
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.48
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.46
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.45
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.45
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.45
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.43
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.4
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 1.39
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.37
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 1.33
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.28
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.28
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.28
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.25
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.21
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.19
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.18
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.13
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.04
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.02
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.02
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.0
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.0
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.99
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.9
p63 controls the enhancer landscape during keratinocyte differentiation 0.9
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.87
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.87
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.83
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.78
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.78
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.75
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.75
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.74
The DPYSL2 gene connects mTOR and schizophrenia 0.73
Function and hormonal regulation of GATA3 in human first trimester placentation 0.71
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.69
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.66
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.64
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.63
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.61
The cohesin release factor WAPL restricts chromatin loop extension. 0.53
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.53
A code of mono-phosphorylation modulates the function of RB. 0.51
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.47
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.46
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.44
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.4
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.38
Leucegene: AML sequencing (part 6) 0.36
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.36
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.32
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.32
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.29
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.29
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.25
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.21
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.21
Modulation of nonsense-mediated decay by rapamycin 0.2
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.2
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.09
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.07
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.06
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.03
Gene expression analysis in response to hypoxic pathway inhibition 0.03
siRNA-mediated knockdown 0.01
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.01
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.01
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation